PureTech Health Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for PureTech Health in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for PureTech Health.

Recommendation Trends

Rating	Apr '24	May '24	Jun '24	Jul '24	Aug '24
Strong Buy	0	0	0	0	0
Buy	2	2	2	2	2
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Faisal Khurshid Leerink Partners	Leerink Partners	Buy Initiates $45	Buy	Initiates	$45	+153.52%	Sep 9, 2024
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $37 → $44	Buy	Maintains	$37 → $44	+147.89%	Aug 25, 2022
Thomas Smith SVB Leerink	SVB Leerink	Buy Maintains $66 → $70	Buy	Maintains	$66 → $70	+294.37%	Aug 9, 2022
Thomas Smith SVB Leerink	SVB Leerink	Buy Maintains $70 → $66	Buy	Maintains	$70 → $66	+271.83%	Jun 15, 2022
Thomas Smith SVB Leerink	SVB Leerink	Buy Maintains $76 → $70	Buy	Maintains	$76 → $70	+294.37%	Jan 7, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 4.83M

Revenue Next Year

n/a

EPS This Year

-0.61

from 0.21

EPS Next Year

-0.66

from -0.61

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	11.77M	17.39M	15.62M	3.33M	4.83M	-	-
Revenue Growth	20.00%	47.76%	-10.18%	-78.68%	44.99%	-	-
EPS	0.02	-0.21	-0.18	-0.24	0.21	-0.61	-0.66
EPS Growth	-98.61%	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-0.63	-0.68
Avg	-0.61	-0.66
Low	-0.59	-0.64

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.